Chronic Granulomatous Disease
Symptoms, Doctors, Treatments, Advances & More

Save information for later
Sign Up

Learn About Chronic Granulomatous Disease

What is the definition of Chronic Granulomatous Disease?

Chronic granulomatous disease is a disorder that causes the immune system to malfunction, resulting in a form of immunodeficiency. Immunodeficiencies are conditions in which the immune system is not able to protect the body from foreign invaders such as bacteria and fungi. Individuals with chronic granulomatous disease may have recurrent bacterial and fungal infections. People with this condition may also have areas of inflammation (granulomas) in various tissues that can result in damage to those tissues. The features of chronic granulomatous disease usually first appear in childhood, although some individuals do not show symptoms until later in life.

What are the causes of Chronic Granulomatous Disease?

Mutations in the CYBA, CYBB, NCF1, NCF2, or NCF4 gene can cause chronic granulomatous disease. There are five types of this condition that are distinguished by the gene that is involved. The proteins produced from the affected genes are parts (subunits) of an enzyme complex called NADPH oxidase, which plays an essential role in the immune system. Specifically, NADPH oxidase is primarily active in immune system cells called phagocytes. These cells catch and destroy foreign invaders such as bacteria and fungi. Within phagocytes, NADPH oxidase is involved in the production of a toxic molecule called superoxide. Superoxide is used to generate other toxic substances, which play a role in killing foreign invaders and preventing them from reproducing in the body and causing illness. NADPH oxidase is also thought to regulate the activity of immune cells called neutrophils. These cells play a role in adjusting the inflammatory response to optimize healing and reduce injury to the body.

How prevalent is Chronic Granulomatous Disease?

Chronic granulomatous disease is estimated to occur in 1 in 200,000 to 250,000 people worldwide.

Is Chronic Granulomatous Disease an inherited disorder?

When chronic granulomatous disease is caused by mutations in the CYBB gene, the condition is inherited in an X-linked recessive pattern. The CYBB gene is located on the X chromosome, which is one of the two sex chromosomes. In males (who have only one X chromosome), one altered copy of the gene in each cell is sufficient to cause the condition. In females (who have two X chromosomes), a mutation would have to occur in both copies of the gene to cause the disorder. Because it is unlikely that females will have two altered copies of this gene, males are affected by X-linked recessive disorders much more frequently than females. A characteristic of X-linked inheritance is that fathers cannot pass X-linked traits to their sons. Rarely, females with one altered copy of the CYBB gene have mild symptoms of chronic granulomatous disease, such as an increased frequency of bacterial or fungal infections.

Who are the top Chronic Granulomatous Disease Local Doctors?
Elite in Chronic Granulomatous Disease
Elite in Chronic Granulomatous Disease
Referral may be required
Queen Victoria Road, 
Newcastle Upon Tyne, ENG, GB 

Andrew Gennery practices practicing medicine in Newcastle Upon Tyne, United Kingdom. Mr. Gennery is rated as an Elite expert by MediFind in the treatment of Chronic Granulomatous Disease. He is also highly rated in 28 other conditions, according to our data. His clinical expertise encompasses Severe Combined Immunodeficiency (SCID), Primary Immunodeficiency (PID), Chronic Granulomatous Disease, Bone Marrow Transplant, and Heart Transplant.

Elite in Chronic Granulomatous Disease
Allergy and Immunology
Elite in Chronic Granulomatous Disease
Allergy and Immunology
Referral may be required

Johns Hopkins All Children's Outpatient Care, St. Petersburg

601 5th Street South, Suite 320, Suite 320, 
Saint Petersburg, FL 
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Jennifer Leiding is an Allergy and Immunologist practicing medicine in Saint Petersburg, Florida. Dr. Leiding is rated as an Elite provider by MediFind in the treatment of Chronic Granulomatous Disease. She is also highly rated in 10 other conditions, according to our data. Her clinical expertise encompasses Chronic Granulomatous Disease, Primary Immunodeficiency (PID), Severe Combined Immunodeficiency (SCID), and Infantile Neutropenia. Dr. Leiding is board certified in American Board Of Allergy And Immunology and American Board Of Pediatrics. Dr. Leiding is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Chronic Granulomatous Disease
Elite in Chronic Granulomatous Disease
Referral may be required
Paris, FR 

Felipe Suarez practices practicing medicine in Paris, France. Mr. Suarez is rated as an Elite expert by MediFind in the treatment of Chronic Granulomatous Disease. He is also highly rated in 30 other conditions, according to our data. His clinical expertise encompasses Chronic Granulomatous Disease, Primary Immunodeficiency (PID), Ataxia-Telangiectasia, Bone Marrow Transplant, and Splenectomy.

What are the latest Chronic Granulomatous Disease Clinical Trials?
NADPH Oxidase Correction in mRNA Transfected Granulocyte-enriched Cells in Chronic Granulomatous Disease (CGD)

Background: CGD is caused by a gene mutation. For people with CGD, their cells cannot kill germs well, so they can get frequent or life-threatening infections. Researchers want to see if a new procedure can help a person s cells kill germs for a short time. It uses messenger RNA (mRNA) to deliver correct instructions for the gene mutation to the cells.

Match to trials
Find the right clinical trials for you in under a minute
Get started
Screening and Baseline Assessment of Patients With Abnormalities of Immune Function

Summary: This study will evaluate patients with abnormal immune function that results in recurrent or unusual infections or chronic inflammation. This may include inherited conditions, such as X-linked severe combined immunodeficiency (XSCID), chronic granulomatous disease (CGD), and leukocyte adhesion deficiency (LAD), or conditions resulting from outside factors, such as graft-versus-host disease (GVHD)....

Who are the sources who wrote this article ?

Published Date: January 01, 2016
Published By: National Institutes of Health